Drug-induced side effects affecting the gastrointestinal tract

被引:34
作者
Leong, Rupert W. L. [1 ]
Chan, Francis K. L. [1 ]
机构
[1] Univ New S Wales, Lidcombe Hosp, Fac Med, Dept Gastroenterol & Hepatol, Bankstown, NSW 2200, Australia
关键词
aspirin; diaphragm; haemorrhage; NSAID; oesophagitis; perforation; ulcer;
D O I
10.1517/14740338.5.4.585
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
With the ever-growing armamentarium of pharmacological agents, the gastrointestinal drug-induced side effects of dyspepsia, nausea, vomiting, diarrhoea and constipation are increasingly seen. They are often self-limiting and without serious sequelae, but of greater concern is drug-induced mucosal ulceration that can manifest as gastrointestinal haemorrhage, stricture and perforation. These complications are mainly attributable to NSAlDs and aspirin, which can injure the mucosa anywhere along the gastrointestinal tract. These iatrogenic serious side effects can be reduced with co-prescription of a proton pump inhibitor, substitution of a COX-2 inhibitor and eradication of Helicobacter pylori when the bacterium is present. Other recognised gastrointestinal complications include small intestinal diaphragm, microscopic colitis, a range of hepatotoxic effects and pancreatitis. The introduction of new classes of drugs has resulted in new adverse effects that require consideration in patients presenting with gastroenterological symptoms. These include pill oesophagitis from bisphosphonates and ischaemic colitis relating to serotonin antagonists. Here, the authors review the literature on drug-induced complications of the gastrointestinal tract and present the pertinent management issues relevant to clinical practice.
引用
收藏
页码:585 / 592
页数:8
相关论文
共 67 条
[21]  
Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2
[22]   DIAPHRAGM DISEASE OF THE ASCENDING COLON - ASSOCIATION WITH SUSTAINED-RELEASE DICLOFENAC [J].
HALTER, F ;
WEBER, B ;
HUBER, T ;
EIGENMANN, F ;
FREY, MP ;
RUCHTI, C .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1993, 16 (01) :74-80
[23]   Orlistat for the long-term treatment of obesity [J].
Harp, JB .
DRUGS OF TODAY, 1999, 35 (02) :139-145
[24]   Safety profile of tegaserod, a 5-HT4 receptor agonist, for the treatment of irritable bowel syndrome [J].
Hasler, WL ;
Schoenfeld, P .
DRUG SAFETY, 2004, 27 (09) :619-631
[25]   Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis [J].
Hippisley-Cox, J ;
Coupland, C ;
Logan, R .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7528) :1310-1312B
[26]  
HUI AJ, 2004, ENCY GASTROENTEROLOG, P157
[27]   EFFECTS OF CHOLESTYRAMINE AND SYNTHETIC HYDROTALCITE ON ACUTE GASTRIC OR INTESTINAL LESION FORMATION IN RATS AND DOGS [J].
ISHIHARA, Y ;
OKABE, S .
DIGESTIVE DISEASES AND SCIENCES, 1981, 26 (06) :553-560
[28]   Effect of nifedipine administration (10mg) on esophageal acid exposure time [J].
Ishikawa, H ;
Iwakiri, K ;
Sugiura, T ;
Kobayashi, M .
JOURNAL OF GASTROENTEROLOGY, 2000, 35 (01) :43-46
[29]   Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use [J].
Laine, L ;
Connors, LG ;
Reicin, A ;
Hawkey, CJ ;
Burgos-Vargas, R ;
Schnitzer, TJ ;
Yu, QF ;
Bombardier, C .
GASTROENTEROLOGY, 2003, 124 (02) :288-292
[30]   A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use [J].
Lanas, A ;
Perez-Aisa, MA ;
Feu, F ;
Ponce, J ;
Saperas, E ;
Santolaria, S ;
Rodrigo, L ;
Balanzo, J ;
Bajador, E ;
Almela, P ;
Navarro, JM ;
Carballo, F ;
Castro, M ;
Quintero, E .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (08) :1685-1693